Stockreport

Insulet’s SECURE-T2D Pivotal Trial Results Demonstrate Omnipod® 5 Improves Clinical Outcomes and Quality of Life in Type 2 Diabetes

Insulet Corporation  (PODD) 
Last insulet corporation earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.insulet.com/investor-relations
PDF Largest, longest, and most racially diverse study of automated insulin delivery (AID) conducted in people with type 2 diabetes to date ACTON, Mass.--(BUSINESS WIRE)-- [Read more]